Search

OBJECTIVES: Many cancer survivors report issues with cognitive function following diagnosis and treatment. The purpose of this single-arm pilot study was to test the feasibility and acceptability of virtual delivery of a cognitive rehabilitation intervention for participants in virtual groups. SAMPLE & SETTING: 37 adult cancer survivors reporting impaired cognitive function following primary treatment were enrolled from Cedars-Sinai Medical Center and affiliates, the University of Kansas Cancer Center, and the Masonic Cancer Alliance. METHODS & VARIABLES: Two cohorts attended six weekly virtual sessions and completed pre- and postintervention patient-reported outcome questionnaires designed to measure perceived cognitive function, loneliness, and determinants of behavior change for exercise, sleep, and mindfulness. RESULTS: Postintervention scores for perceived cognitive function, determinants of behavior change, and loneliness ratings significantly improved. IMPLICATIONS FOR NURSING: Evidence continues to build in support of cognitive rehabilitation interventions for cancer survivors. Nurses play an important role in terms of patient identification, participation, and facilitation. [ABSTRACT FROM AUTHOR]

Background: There is a need for low-risk nonpharmaceutical methods to support psychosocial distress associated with breast cancer (BC). This study aimed to evaluate the feasibility and impact of an improvisational theater (improv) program for BC survivors. Methods: Female BC survivors (n = 17) participated in a six-week improv program. Feasibility was assessed through attendance frequency and percentage attrition. The Functional Assessment of Cancer Therapy-General (FACT-G), the Patient Reported Outcomes Measurement Information System, Version 29 (PROMIS-29), and the University of California, Los Angeles (UCLA) Loneliness Scale were used to measure well-being and quality of life at three time points: baseline, end of program, and one-month follow-up. Changes in these measures were assessed using a linear mixed-effects model. Results: The program had low attrition (5.88%) and high attendance (94%). FACT-G and loneliness scores improved significantly between baseline and end of program (p's < 0.05). Changes in FACT-G remained significant at follow-up (P = 0.009). Significant improvements between baseline and the end of the program were also present for anxiety, depression, fatigue, and ability to participate in social roles/activities as measured by the PROMIS-29 (p's < 0.05). Changes in anxiety and depression remained significant at follow-up (p's < 0.05). Conclusion: Improv represents a novel method for supporting the quality of life and well-being of BC survivors. This is the first study to examine improv among BC survivors. Findings demonstrate that an improv intervention is feasible in this population. A larger randomized controlled trial is warranted to more fully examine the impact of this novel intervention. [ABSTRACT FROM AUTHOR]

OBJECTIVES: To gather feasibility and preliminary data comparing two virtual delivery methods for providing Emerging From the Haze™ (Haze) to cancer survivors compared to waitlist control (WLC). SAMPLE & SETTING: Eligible participants (N = 93) reported cancer-related cognitive impairment following chemotherapy for stage I-III solid tumors, Hodgkin lymphoma, or non-Hodgkin lymphoma. METHODS & VARIABLES: A three-arm randomized design was used to compare virtual live group presentation of Haze sessions, virtual prerecorded Haze group sessions, and WLC. Data were collected at baseline, week 10, and week 14. RESULTS: Feasibility was demonstrated. Significant cognitive function improvement at week 10 versus WLC was reported for the live group, and clinical improvement was reported for the prerecorded group. The prerecorded group reported significant improvement at week 14 versus WLC in physical activity, sleep, and health-related quality of life. IMPLICATIONS FOR NURSING: Additional pilot and feasibility evidence for cognitive rehabilitation interventions was demonstrated. Prerecorded Haze delivery shows potential for clinical effectiveness and scalability. Future multisite research is warranted. [ABSTRACT FROM AUTHOR]